{"id":275877,"date":"2026-09-29T09:33:07","date_gmt":"2026-09-29T04:03:07","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=275877"},"modified":"2026-10-22T11:02:08","modified_gmt":"2026-10-22T05:32:08","slug":"why-pfizer-ltd-share-near-52-week-consecutive-low-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-near-52-week-consecutive-low-2026\/","title":{"rendered":"Pfizer Ltd. (PFIZER) 52 Week Low Streak Extends to Fourth Session"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/pfizer\/pfizer-ltd-share-price-today\">Pfizer Ltd. (PFIZER)<\/a> share price is trading within 2% of its 52-week low today and stood at Rs 3,735, down 0.73% from the previous close. Market cap was Rs 17,417.08 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;\"><strong>Pfizer Ltd. (PFIZER) has now traded within 2% of its 52-week low for its fourth consecutive session, with a cumulative decline of 4.84% across the streak. During the current move, the stock touched a low of Rs 3,684.55 and was last trading at Rs 3,735. The latest Univest data confirms the repeated-low pattern, but it does not establish any company-specific cause for the continued weakness.<\/strong><\/p>\n<p><strong>At 10:52 AM IST, the previous close stood at Rs 3,762.3, while the stock opened at Rs 3,764.95 and touched a high of Rs 3,765. The market capitalisation stood at Rs 17,417.08 crore, placing the current decline in the context of a large listed pharma business that is still being priced close to its yearly low. For readers, the repeated pattern matters more than a single session because it shows persistent pressure across several trading days rather than one isolated move.<\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-near-52-week-consecutive-low-2026\/#Pfizer_Ltd_52_Week_Low_Streak_Consecutive_Low_Analysis\" title=\"Pfizer Ltd. 52 Week Low Streak: Consecutive Low Analysis\">Pfizer Ltd. 52 Week Low Streak: Consecutive Low Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-near-52-week-consecutive-low-2026\/#What_the_Repeated_52-Week_Lows_Show\" title=\"What the Repeated 52-Week Lows Show\">What the Repeated 52-Week Lows Show<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-near-52-week-consecutive-low-2026\/#Pfizer_Ltd_PFIZER_Fundamental_Analysis\" title=\"Pfizer Ltd. (PFIZER) Fundamental Analysis\">Pfizer Ltd. (PFIZER) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-near-52-week-consecutive-low-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-near-52-week-consecutive-low-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-near-52-week-consecutive-low-2026\/#Why_Investors_Are_Watching\" title=\"Why Investors Are Watching\">Why Investors Are Watching<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-near-52-week-consecutive-low-2026\/#About_the_Company\" title=\"About the Company\">About the Company<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-near-52-week-consecutive-low-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-near-52-week-consecutive-low-2026\/#Why_is_Pfizer_Ltd_still_near_its_52-week_low\" title=\"Why is Pfizer Ltd. still near its 52-week low?\">Why is Pfizer Ltd. still near its 52-week low?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-near-52-week-consecutive-low-2026\/#How_does_Pfizer_Ltd_compare_with_peers_on_valuation\" title=\"How does Pfizer Ltd. compare with peers on valuation?\">How does Pfizer Ltd. compare with peers on valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-near-52-week-consecutive-low-2026\/#Is_Pfizer_Ltd_expensive_compared_with_the_sector\" title=\"Is Pfizer Ltd. expensive compared with the sector?\">Is Pfizer Ltd. expensive compared with the sector?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-near-52-week-consecutive-low-2026\/#What_fundamental_metrics_stand_out_for_Pfizer_Ltd\" title=\"What fundamental metrics stand out for Pfizer Ltd.?\">What fundamental metrics stand out for Pfizer Ltd.?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-near-52-week-consecutive-low-2026\/#What_should_investors_monitor_next_in_Pfizer_Ltd_stock_news\" title=\"What should investors monitor next in Pfizer Ltd. stock news?\">What should investors monitor next in Pfizer Ltd. stock news?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-near-52-week-consecutive-low-2026\/#Track_Pfizer_Ltd_PFIZER_Share_Price_on_Univest\" title=\"Track Pfizer Ltd. (PFIZER) Share Price on Univest\">Track Pfizer Ltd. (PFIZER) Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Pfizer_Ltd_52_Week_Low_Streak_Consecutive_Low_Analysis\"><\/span><strong>Pfizer Ltd. 52 Week Low Streak: Consecutive Low Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,735<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,762.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -27.3 (-0.73%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,764.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,765<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,684.55<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 17,417.08 crore<\/td>\n<\/tr>\n<\/table>\n<p>Pfizer Ltd. (PFIZER) traded at Rs 3,735 versus the previous close of Rs 3,762.3, a fall of 0.73%. The stock opened at Rs 3,764.95, reached a high of Rs 3,765, touched a low of Rs 3,684.55.<\/p>\n<p>Pfizer Ltd. share price today is lower by Rs 27.3, or 0.73%, versus the previous close of Rs 3,762.3, with the stock last trading at Rs 3,735. The day opened almost flat at Rs 3,764.95 and then moved down to an intraday low of Rs 3,684.55 before recovering part of the drop. The highest point seen so far is Rs 3765, which shows that the price has stayed near the upper end only briefly before slipping back toward the lower band of the day.<\/p>\n<p>That intraday structure keeps the Pfizer Ltd. share price in focus because the move remains aligned with the broader 52-week low streak rather than a one-off dip. The market capitalisation of Rs 17,417.08 crore indicates a substantial listed company, so the present weakness is being watched through both the stock price and the company\u2019s valuation profile. For anyone tracking Pfizer Ltd. stock news, the key point is not just the day\u2019s decline, but the fact that the stock is still hovering close to its one-year trough for a fourth straight session. This is a decline story, and the price action continues to reflect that pattern.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_the_Repeated_52-Week_Lows_Show\"><\/span><strong>What the Repeated 52-Week Lows Show<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The extended streak shows that Pfizer Ltd. has not merely tested its yearly low once; it has kept trading within 2% of that level across four consecutive sessions. Across the full stretch, the cumulative move is down 4.84%, which gives a clearer read than the day\u2019s change alone. That wider move is the main differentiator in a Pfizer Ltd. 52 Week Low Streak article, because it highlights a sustained pattern of weakness rather than a single-day event.<\/p>\n<p>For market readers, the repeated placement near the one-year low means the stock remains under pressure across successive sessions. The latest Univest data confirms that pattern, but it does not confirm a company-specific trigger for why the stock has remained near this range. In other words, the numbers show persistence, not a verified reason. That distinction matters because a repeated low can continue for several sessions without a fresh headline, and the data here supports that reading. The move also keeps the Pfizer Ltd. share price under close watch in the context of broader stock performance.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Pfizer_Ltd_PFIZER_Fundamental_Analysis\"><\/span><strong>Pfizer Ltd. (PFIZER) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 17,417.08 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">23.41x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.91x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">17.16%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">23.39%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 160.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 963.41<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.99%<\/td>\n<\/tr>\n<\/table>\n<p>Pfizer Ltd. (PFIZER) fundamental metrics show P\/E 23.41x, P\/B 3.91x, ROE 17.16%, ROCE 23.39%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Pfizer Ltd. has a market capitalisation of Rs 17,417.08 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 23.41x, P\/B at 3.91x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 17.16% and ROCE of 23.39%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 160.7, book value per share of Rs 963.41, dividend yield of 1.99%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 27.02x, median ROE of 11.23%, median ROCE of 13.17%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">23.41x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.02x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">38.85x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 616.23x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.91x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.67x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">17.16%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.23%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">23.39%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.17%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 17,417.08 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 768.75 crore<\/td>\n<\/tr>\n<\/table>\n<p>Pfizer Ltd. (PFIZER) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Pfizer Ltd. (PFIZER) has a P\/E ratio of 23.41x, which is below the benchmark median of 27.02x, a difference of -13.36%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Pfizer Ltd. (PFIZER) has a ROE of 17.16%, which is above the benchmark median of 11.23%, a difference of +52.8%. Pfizer Ltd. (PFIZER) has a ROCE of 23.39%, which is above the benchmark median of 13.17%, a difference of +77.6%.<\/p>\n<p>Track stocks falling to yearly lows through the <a href=\"https:\/\/univest.in\/screeners\/52-week-low\">Univest 52-week-low screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cohance\/suven-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Suven Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">COHANCE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">17,513.39<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">165.48<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.57<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.02<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.12<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/caplipoint\/caplin-point-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Caplin Point Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CAPLIPOINT<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">17,194.23<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.38<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.79<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">24.97<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/shilpamed\/shilpa-medicare-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Shilpa Medicare Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SHILPAMED<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">17,131.99<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">55.58<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.15<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.82<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.43<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/onesource\/onesource-specl-pharma-l-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>ONESOURCE SPECL PHARMA L<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ONESOURCE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15,818.68<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-1.26<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0.44<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/natcopharm\/natco-pharma-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Natco Pharma Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">NATCOPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15,708.15<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.46<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.3<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">17.16<\/td>\n<\/tr>\n<\/table>\n<p>Pfizer Ltd. (PFIZER) has a P\/E ratio of 23.41x compared with the displayed peer median of 25.38x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 17.16% compares with a peer median of 9.82% across the companies shown in the table. ROCE stood at 23.39% versus the displayed peer median of 11.43%, providing a capital-efficiency comparison. Pfizer Ltd. (PFIZER) has a market capitalisation of Rs 17,417.08 crore. Among the 5 peers shown, only 1 has a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching\"><\/span><strong>Why Investors Are Watching<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>The stock has traded within 2% of its 52-week low for a fourth consecutive session, which makes the Pfizer Ltd. 52 Week Low Streak more than a one-day event.<\/li>\n<li>The cumulative decline across the streak is 4.84%, giving a better read on the full weakness than the latest move alone.<\/li>\n<li>The latest Univest data confirms the repeated-low pattern, but it does not establish a company-specific cause for the continued move.<\/li>\n<li>Pfizer Ltd. is still valued above the industry median on P\/B while trading below the industry median on P\/E, so the valuation picture is mixed.<\/li>\n<li>The stock\u2019s profitability ratios remain above the industry median, so investors will likely keep watching whether price weakness persists despite solid return metrics.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_the_Company\"><\/span><strong>About the Company<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Pfizer Ltd. is part of the Healthcare sector and the Pharmaceuticals &amp; Drugs industry in India. The company\u2019s market capitalisation stands at Rs 17,417.08 crore, and its latest profitability metrics show ROE of 17.16% and ROCE of 23.39%. The stock is tracked on both NSE and BSE, and its current share price action remains central to Pfizer Ltd. stock performance discussions.<\/p>\n<p>For readers following Pfizer Ltd. share price update alongside company financials, the main point is that the stock remains a sizeable listed pharma name with mixed valuation signals. The current near 52-week low pattern does not by itself explain the business outlook, but it does make the company\u2019s earnings quality, book value and sector comparison more relevant for ongoing monitoring.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Pfizer_Ltd_still_near_its_52-week_low\"><\/span><strong>Why is Pfizer Ltd. still near its 52-week low?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Pfizer Ltd. has traded within 2% of its 52-week low for four consecutive sessions. The data confirms the pattern, but it does not establish a company-specific cause for the continued weakness.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Pfizer_Ltd_compare_with_peers_on_valuation\"><\/span><strong>How does Pfizer Ltd. compare with peers on valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Pfizer Ltd. trades at a P\/E of 23.41 and a P\/B of 3.91. That places it below the industry median on earnings multiple but above the median on book value multiple.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Pfizer_Ltd_expensive_compared_with_the_sector\"><\/span><strong>Is Pfizer Ltd. expensive compared with the sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The answer is mixed. Its P\/E is below the industry median, but its P\/B is above the median. Investors should view the valuation in the context of profitability and peer comparison.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_fundamental_metrics_stand_out_for_Pfizer_Ltd\"><\/span><strong>What fundamental metrics stand out for Pfizer Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> ROE of 17.16% and ROCE of 23.39% stand out positively versus the industry median. EPS of Rs 160.7 and book value of Rs 963.41 are also important markers in the current Pfizer Ltd. stock analysis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_next_in_Pfizer_Ltd_stock_news\"><\/span><strong>What should investors monitor next in Pfizer Ltd. stock news?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should watch whether the stock continues to trade near its yearly low, how the share price behaves relative to the latest range, and whether future updates change the valuation or fundamental picture.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Pfizer_Ltd_PFIZER_Share_Price_on_Univest\"><\/span><strong>Track Pfizer Ltd. (PFIZER) Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/pfizer\/pfizer-ltd-share-price-today\">Pfizer Ltd. (PFIZER) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-low\">Univest 52-week-low screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-low lists and related market analysis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pfizer Ltd. Share Price trades near its 52-week low at Rs 3,735, marking a 0.73% decline today. Market cap stands at Rs 17,417.08 crore.<\/p>\n","protected":false},"author":38,"featured_media":323057,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-275877","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["323057"],"rank_math_title":["Pfizer Ltd. 52 Week Low Streak: Four Sessions of Weakness"],"rank_math_description":["Pfizer Ltd. 52 Week Low Streak: Pfizer Ltd. has traded near its 52-week low for a fourth straight session. Read the price action, valuation and sector"],"rank_math_focus_keyword":["Pfizer Ltd. 52 Week Low Streak"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/pfizer-ltd-pfizer-52-week-low-streak-extends-to-fourth-session.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/275877","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=275877"}],"version-history":[{"count":6,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/275877\/revisions"}],"predecessor-version":[{"id":323059,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/275877\/revisions\/323059"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/323057"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=275877"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=275877"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=275877"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}